Filing Details

Accession Number:
0001209191-13-028263
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 20:33:40
Reporting Period:
2013-05-20
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 20:33:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389072 Heartware International Inc. HTWR Surgical & Medical Instruments & Apparatus (3841) 980498958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404477 Bain Robert Thomas C/O Heartware International, Inc.
205 Newbury St., Suite 101
Framingham MA 01701
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-20 1,928 $97.66 11,582 No 4 S Direct
Common Stock Disposition 2013-05-20 572 $98.34 11,010 No 4 S Direct
Common Stock Disposition 2013-05-20 2,500 $98.73 8,870 No 4 S Indirect See footnote
Common Stock Disposition 2013-05-21 200 $97.69 8,670 No 4 S Indirect See footnote
Common Stock Disposition 2013-05-20 714 $98.35 10,000 No 4 S Indirect See footnote
Common Stock Disposition 2013-05-20 715 $97.34 9,285 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2013-05-21 1,000 $0.00 1,000 $95.05
Common Stock Restricted Stock Unit Acquisiton 2013-05-21 1,000 $0.00 1,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,000 2023-05-21 No 4 A Direct
2,250 2017-05-21 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Indirect See footnote
Footnotes
  1. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $97.18 to $97.97. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  2. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $98.21 to $98.52. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Robert Thomas as Trustee of the RB Thomas Superannuation Fund.
  4. The sale was executed in the form of the Company's Chess Depository Interests ("CDI's"), trading on the Australian Securities Exchange. The number of shares sold has been determined based on the ratio of 1 share of common stock per 35 CDI's.
  5. The sale price have been converted from Australian dollars to the U.S. dollar equivalent at the spot rate on the date of the transaction.
  6. Held by Mr. Thomas' spouse, Mrs. Kyrenia Thomas.
  7. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $97.33 to $97.67. The sale prices have been converted from Australian dollars to the U.S. dollar equivalent at the spot rate on the date of the transaction. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  8. Robert Thomas as Trustee of the Thomas Family Account.
  9. The stock options become exercisable in four equal installments on May 1, 2014, May 1, 2015, May 1, 2016 and May 1, 2017 subject to Mr. Thomas' continuous service as a director of the Company through each date. In addition, the stock options will immediately vest upon the occurrence of a change in control (as defined in the 2012 Incentive Award Plan) or upon Mr. Thomas' death prior to settlement.
  10. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  11. The restricted stock units become exercisable in four equal installments on May 1, 2014, May 1, 2015, May 1, 2016 and May 1, 2017 subject to Mr. Thomas' continuous service as a director of the Company through each date. In addition, the restricted stock units will immediately vest upon the occurrence of a change in control (as defined in the 2012 Incentive Award Plan) or upon Mr. Thomas' death prior to settlement.